Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,881,355
+$2,440,077 QoQ
Shares Held
3,236
+106.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
#1,918
of 4,605 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RATIONAL ADVISORS, INC. holds $5,864,979 across 4 Drug Manufacturers - General names. LLY ranks #1 (66.2% of the industry book) .
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,881,355 | 3,236 | Shares | Other | 2026-07-24 | |
| 2026-03-31 | $1,441,278 | 1,567 | Shares | Other | 2026-05-07 | |
| 2025-12-31 | $3,143,438 | 2,925 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $897,288 | 1,176 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $2,170,210 | 2,784 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $349,359 | 423 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $546,576 | 708 | Shares | Other | 2025-01-31 | |
| 2024-09-30 | $3,189,384 | 3,600 | Shares | Other | 2024-10-30 | |
| 2024-06-30 | $3,629,668 | 4,009 | Shares | Other | 2024-07-25 | |
| 2024-03-31 | $2,917,350 | 3,750 | Shares | Other | 2024-04-23 | |
| 2023-09-30 | $1,826,242 | 3,400 | Shares | Other | 2023-11-09 | |
| 2023-06-30 | $2,063,512 | 4,400 | Shares | Other | 2023-08-08 | |
| 2023-03-31 | $1,923,152 | 5,600 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $762,776 | 2,085 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $818,398 | 2,531 | Shares | Other | 2022-11-08 | |
| 2020-09-30 | $53,730 | 363 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $3,119 | 19 | Shares | Other | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||